Home Cart Sign in  
Chemical Structure| 119425-89-7 Chemical Structure| 119425-89-7

Structure of Loureirin A
CAS No.: 119425-89-7

Chemical Structure| 119425-89-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Loureirin A is a flavonoid isolated from Dragon's Blood. It reduces Akt phosphorylation and has antiplatelet aggregation effects.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Loureirin A

CAS No. :119425-89-7
Formula : C17H18O4
M.W : 286.32
SMILES Code : O=C(C1=CC=C(O)C=C1)CCC2=CC=C(OC)C=C2OC
MDL No. :MFCD10566607

Safety of Loureirin A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of Loureirin A

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Red blood cells 0-280 µM 4 hours Evaluate the hemolytic effect of Loureirin A on red blood cells, showing no hemolysis at 0-280 µM. Life (Basel). 2025 Mar 3;15(3):396
Primary human dermal fibroblast cells 0-350 µM 24 and 48 hours Evaluate the toxicity of Loureirin A on primary human dermal fibroblast cells, showing no toxicity at 0-350 µM. Life (Basel). 2025 Mar 3;15(3):396
H1299 cells 0-140 µM 24 hours Evaluate the effect of Loureirin A on the viability of H1299 cells, showing no toxicity at 0-140 µM. Life (Basel). 2025 Mar 3;15(3):396
A549 cells 0-140 µM 24 hours Evaluate the effect of Loureirin A on the viability of A549 cells, showing no toxicity at 0-140 µM. Life (Basel). 2025 Mar 3;15(3):396
hair follicle stem cells 20 µg/ml 24 hours To investigate the effect of Loureirin A on hair follicle stem cell differentiation, results showed that Loureirin A promoted HFSC differentiation by downregulating miR‑339‑5p. Mol Med Rep. 2018 Aug;18(2):1279-1286
Various non-Helicobacter strains 32 µg/mL to >128 µg/mL To evaluate the antimicrobial spectrum of LrA against various non-Helicobacter strains, results showed that LrA's activity against these strains was at least eight times higher than against H. pylori, indicating LrA is a narrow-spectrum anti-H. pylori molecule. Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0031424

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice H. pylori infection model Oral gavage 28 mg/kg Once daily for 4 consecutive days To evaluate the therapeutic efficacy of LrA combined with OPZ in H. pylori-infected mouse models, results showed that the LrA + OPZ treatment group reduced colony counts of multidrug-resistant H. pylori by 2.6 orders of magnitude, comparable to triple therapy, and had minimal impact on the diversity and composition of mouse gut microbiota. Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0031424

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.49mL

0.70mL

0.35mL

17.46mL

3.49mL

1.75mL

34.93mL

6.99mL

3.49mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories